现代中西医结合杂志
現代中西醫結閤雜誌
현대중서의결합잡지
Modern Journal of Integrated Traditional Chinese and Western Medicine
2015年
33期
3675-3677
,共3页
康海燕%董江龙%李健%陈蕾%叶立红%王艳%王晓静%王晨雪
康海燕%董江龍%李健%陳蕾%葉立紅%王豔%王曉靜%王晨雪
강해연%동강룡%리건%진뢰%협립홍%왕염%왕효정%왕신설
乙型肝炎%医用臭氧%聚乙二醇干扰素α-2a%HBeAg定量%HBsAg定量%FibroScan
乙型肝炎%醫用臭氧%聚乙二醇榦擾素α-2a%HBeAg定量%HBsAg定量%FibroScan
을형간염%의용취양%취을이순간우소α-2a%HBeAg정량%HBsAg정량%FibroScan
hepatitis B%medical ozone%polyethylene glycol interferon α-2a%HBeAg quantification%HBsAg quantifica-tion%FibroScan
目的:观察医用臭氧对慢性乙型肝炎患者HBeAg、HBsAg及瞬时肝弹性测定(FibroScan)的影响,评估医用臭氧在慢性乙型肝炎患者中的抗病毒、抗纤维化作用。方法将120例HBeAg阳性的慢性乙肝患者随机分成2组,治疗组给予医用臭氧自体血回输治疗(采集患者静脉抗凝全血100 mL,在其中缓慢注入100 mL 30μg/mL医用臭氧,然后再回输到静脉),每周3次;对照组给予聚乙二醇干扰素α-2 a 180μg皮下注射,每周1次。观察2组治疗4周、8周、12周时血清HBsAg、HBeAg定量及FibroScan的变化。结果2组在治疗4周、8周、12周时血清HBsAg、HBeAg定量及FibroScan均逐渐下降(P均<0.05);2组间各指标比较差异无统计学意义(P均>0.05);患者血清HB-sAg定量、HBeAg定量与FibroScan之间呈正相关(r=0.764,0.779,P均<0.05)。结论医用臭氧自体血回输治疗慢性乙型肝炎与聚乙二醇干扰素α-2a效果相当,其抗病毒、抗纤维化效果确切。
目的:觀察醫用臭氧對慢性乙型肝炎患者HBeAg、HBsAg及瞬時肝彈性測定(FibroScan)的影響,評估醫用臭氧在慢性乙型肝炎患者中的抗病毒、抗纖維化作用。方法將120例HBeAg暘性的慢性乙肝患者隨機分成2組,治療組給予醫用臭氧自體血迴輸治療(採集患者靜脈抗凝全血100 mL,在其中緩慢註入100 mL 30μg/mL醫用臭氧,然後再迴輸到靜脈),每週3次;對照組給予聚乙二醇榦擾素α-2 a 180μg皮下註射,每週1次。觀察2組治療4週、8週、12週時血清HBsAg、HBeAg定量及FibroScan的變化。結果2組在治療4週、8週、12週時血清HBsAg、HBeAg定量及FibroScan均逐漸下降(P均<0.05);2組間各指標比較差異無統計學意義(P均>0.05);患者血清HB-sAg定量、HBeAg定量與FibroScan之間呈正相關(r=0.764,0.779,P均<0.05)。結論醫用臭氧自體血迴輸治療慢性乙型肝炎與聚乙二醇榦擾素α-2a效果相噹,其抗病毒、抗纖維化效果確切。
목적:관찰의용취양대만성을형간염환자HBeAg、HBsAg급순시간탄성측정(FibroScan)적영향,평고의용취양재만성을형간염환자중적항병독、항섬유화작용。방법장120례HBeAg양성적만성을간환자수궤분성2조,치료조급여의용취양자체혈회수치료(채집환자정맥항응전혈100 mL,재기중완만주입100 mL 30μg/mL의용취양,연후재회수도정맥),매주3차;대조조급여취을이순간우소α-2 a 180μg피하주사,매주1차。관찰2조치료4주、8주、12주시혈청HBsAg、HBeAg정량급FibroScan적변화。결과2조재치료4주、8주、12주시혈청HBsAg、HBeAg정량급FibroScan균축점하강(P균<0.05);2조간각지표비교차이무통계학의의(P균>0.05);환자혈청HB-sAg정량、HBeAg정량여FibroScan지간정정상관(r=0.764,0.779,P균<0.05)。결론의용취양자체혈회수치료만성을형간염여취을이순간우소α-2a효과상당,기항병독、항섬유화효과학절。
Objective It is to observe the influence of medical ozone on HBeAg , HBsAg and transient liver elasticity ( Fi-broScan ) in patients with chronic hepatitis B , and evaluate the antiviral and anti fibrosis effects of medical ozone in the treat -ment of chronic hepatitis B patients .Methods 120 patients with HBeAg positive chronic hepatitis B were randomly divided in-to two groups.The patients in the treatment group was treated with medical ozone autologous blood transfusion (anticoagulant venous blood 100 mL was collected from patients , which was slowly injected into the 100 mL 30μg/mL of medical ozone , and then returned to the vein ) , three times a week;the patients in the control group were treated with the polyethylene glycol inter -feron α-2a 180 μg by subcutaneous injection , once a week.The changes of serum HBeAg , HBsAg quantification and Fi-broScan value in the treatment of 4 weeks, 8 weeks, and 12 weeks were observed.Results The serum HBsAg, HBeAg quanti-fication and FibroScan value in the treatment of 4 weeks, 8 weeks, 12 weeks were gradually decreased in the two groups (all P<0.05);and there was no significant difference between the two groups (P>0.05).There was positive correlation between serum HBsAg, HBeAg quantification with FibroScan value (r=0.764, 0.779, all P<0.05).Conclusion The effcet of med-ical ozone autologous blood transfusionin in the treatment of chronic hepatitis B is similar to polyethylene glycol interferon α-2a, and it has the definite effect of anti viral and anti fibrosis .